# XYLOCAINE MPF 1.5% WITH EPINEPHRINE · 5 MCG · LIQUID



## Canada

- **Health Canada** — [ca.dose-10060.org](https://ca.dose-10060.org)

## Codes

- **ca-din** — `00875813`
- **ca-dpd-drug-code** — `10943`

## Status

- **lifecycle** — history
- **status** — CANCELLED POST MARKET
- **status_date** — 2001-10-12
- **status_date_as_published** — 12-OCT-2001
- **status_history** — [{'date': '1997-10-02', 'status': 'MARKETED'}, {'date': '2001-10-12', 'status': 'CANCELLED POST MARKET'}, {'date': '2001-06-14', 'status': 'APPROVED'}, {'date': '1990-12-31', 'status': 'MARKETED'}]
- **effective** — 2001-10-12
- **read** — 2026-11-15T06:54:55Z

## Holder

- ASTRAZENECA L.P.

## Proof

Record ca:authorisation:din:00875813:10943 version 1, signed ES256 under dosidal-record-1.9dbf5d53.

## Contact

Contact: the form at the bottom of https://dosidal.ai/#contact

---
Dosidal is a product record. It identifies a medicine and its regulatory status. It does not advise on use.
Artificial intelligence makes mistakes. Dosidal is an information source, not a recommendation. Read the regulator.
Dosidal is operated by Dosidal AI Corp. Office: 6687 Nelson Avenue, Suite 304, West Vancouver, BC V7W 2B2, Canada.
© 2027 Dosidal AI Corp.
Dosidal · dosidal.ai · Surface 1.0 (2026-11-16)
